Lv2
130 积分 2024-04-19 加入
425eP Neoadjuvant chemoradiotherapy (nCRT) followed by sequential tislelizumab for resectable esophageal squamous cell carcinoma (ESCC): Updated results of a single-arm, open-label phase Ib trial (CRIS)
4个月前
已关闭
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
5个月前
已完结
The Changes of Lymphocytes and Immune Molecules in Irradiated Mice by Different Doses of Radiation
6个月前
已完结
LYMPHOCYTE RESPONSE AFTER RADIOTHERAPY
6个月前
已完结
Overcoming melanoma therapy resistance with RAF-MEK and FAK inhibition
9个月前
已完结
Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma
9个月前
已完结
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
9个月前
已完结
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
9个月前
已完结
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
10个月前
已完结
Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data
10个月前
已完结
皖公网安备34019202002308
